Barclays reiterated coverage of Apple with a rating of Underweight and set a new price target of $248.00 from $239.00 previously
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/3/2026 | $239.00 → $248.00 | Underweight | Barclays |
| 2/25/2026 | $241.00 → $270.00 | Neutral | MoffettNathanson |
| 2/10/2026 | $325.00 → $340.00 | Outperform | Bernstein |
| 1/30/2026 | $315.00 → $325.00 | Overweight | Analyst |
| 1/30/2026 | $230.00 → $239.00 | Underweight | Barclays |
| 1/30/2026 | $250.00 → $267.00 | Neutral | Rosenblatt |
| 1/30/2026 | $300.00 → $315.00 | Buy | Monness Crespi & Hardt |
| 1/30/2026 | $300.00 | Hold → Buy | Maxim Group |
4 - Apple Inc. (0000320193) (Issuer)
4 - Apple Inc. (0000320193) (Issuer)
4 - Apple Inc. (0000320193) (Issuer)
8-K - Apple Inc. (0000320193) (Filer)
10-Q - Apple Inc. (0000320193) (Filer)
8-K - Apple Inc. (0000320193) (Filer)
For Immediate Release: September 17, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice,” which, when finalized, will support the conduct of randomized controlled trials with streamlined protocols a
For Immediate Release: September 12, 2024 Today, the U.S. Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended to be used with compatible versions of the Apple AirPods Pro headphones. Once installed and customized to the user’s hearing needs, the Hearing Aid Feature enables compatible versions of the AirPods Pro to serve as an OTC hea
The world's best pro laptop raises the bar again with blazing-fast CPU and GPU performance, plus up to 2x faster SSD speeds and 1TB of starting storage Apple® today announced the latest 14- and 16-inch MacBook Pro® with the all-new M5 Pro and M5 Max, bringing game-changing performance and AI capabilities to the world's best pro laptop. With M5 Pro and M5 Max, MacBook Pro features a new CPU with the world's fastest CPU core,1 a next-generation GPU with a Neural Accelerator in each core, and higher unified memory bandwidth, altogether delivering up to 4x AI performance compared to the previous generation, and up to 8x AI performance compared to M1 models.2 This allows developers, researcher
Studio Display XDR is the world's best pro display, featuring a 27-inch 5K Retina XDR display with a mini-LED backlight, 2000 nits of peak HDR brightness, and a 120Hz refresh rate Apple® today announced a new family of displays engineered to pair beautifully with Mac® and meet the needs of everyone, from everyday users to the world's top pros. The new Studio Display® features a 12MP Center Stage® camera, now with improved image quality and support for Desk View; a studio-quality three-microphone array; and an immersive six-speaker sound system with Spatial Audio. It also now includes powerful Thunderbolt 5 connectivity, providing more downstream connectivity for high-speed accessories or
Built using the new Apple-designed Fusion Architecture, M5 Pro and M5 Max feature an advanced CPU, a next‑generation GPU with Neural Accelerators, and higher unified memory bandwidth for a massive increase in AI compute Apple® today announced M5 Pro and M5 Max, the world's most advanced chips for pro laptops, powering the new MacBook Pro®. The chips are built using a new Apple-designed Fusion Architecture. This innovative design combines two dies into a single system on a chip (SoC), which includes a powerful CPU, scalable GPU, Media Engine, unified memory controller, Neural Engine, and Thunderbolt 5 capabilities. M5 Pro and M5 Max feature a new 18-core CPU architecture. It includes six o
Barclays reiterated coverage of Apple with a rating of Underweight and set a new price target of $248.00 from $239.00 previously
MoffettNathanson reiterated coverage of Apple with a rating of Neutral and set a new price target of $270.00 from $241.00 previously
Bernstein reiterated coverage of Apple with a rating of Outperform and set a new price target of $340.00 from $325.00 previously
All-time records for total company revenue and EPS iPhone and Services revenue reach new all-time highs Apple® today announced financial results for its fiscal 2026 first quarter ended December 27, 2025. The Company posted quarterly revenue of $143.8 billion, up 16 percent year over year. Diluted earnings per share was $2.84, up 19 percent year over year. "Today, Apple is proud to report a remarkable, record-breaking quarter, with revenue of $143.8 billion, up 16 percent from a year ago and well above our expectations," said Tim Cook, Apple's CEO. "iPhone had its best-ever quarter driven by unprecedented demand, with all-time records across every geographic segment, and Services also
September quarter records for total company revenue, iPhone revenue and EPS Services revenue reaches new all-time high Apple® today announced financial results for its fiscal 2025 fourth quarter ended September 27, 2025. The Company posted quarterly revenue of $102.5 billion, up 8 percent year over year. Diluted earnings per share was $1.85, up 13 percent year over year on an adjusted basis.1 "Today, Apple is very proud to report a September quarter revenue record of $102.5 billion, including a September quarter revenue record for iPhone and an all-time revenue record for Services," said Tim Cook, Apple's CEO. "In September, we were thrilled to launch our best iPhone lineup ever, incl
June quarter records for total company revenue, iPhone revenue and EPS Services revenue reaches new all-time high Apple® today announced financial results for its fiscal 2025 third quarter ended June 28, 2025. The Company posted quarterly revenue of $94.0 billion, up 10 percent year over year, and quarterly diluted earnings per share of $1.57, up 12 percent year over year. "Today Apple is proud to report a June quarter revenue record with double-digit growth in iPhone, Mac and Services and growth around the world, in every geographic segment," said Tim Cook, Apple's CEO. "At WWDC25, we were excited to introduce a beautiful new software design that extends across all of our platforms,
Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S
Jennifer Newstead to join Apple as senior vice president, will become general counsel in March 2026 Kate Adams to retire late next year Lisa Jackson to retire Apple® today announced that Jennifer Newstead will become Apple's general counsel on March 1, 2026, following a transition of duties from Kate Adams, who has served as Apple's general counsel since 2017. She will join Apple as senior vice president in January, reporting to CEO Tim Cook and serving on Apple's executive team. In addition, Lisa Jackson, vice president for Environment, Policy, and Social Initiatives, will retire in late January 2026. The Government Affairs organization will transition to Adams, who will oversee the te
908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Christopher D. Brown, PhD, Vice President, Analytics R&D at Repligen Corporation (NASDAQ:RGEN), and a 908 Devices Co-founder, to serve on its Board of Directors, effective immediately. Dr. Brown co-founded 908 Devices and served as the company's Chief Technology Officer & Vice President of Research & Development from February 2012 to March 2023, and as its Chief Product Officer from March 2023 until March 2025 when Repligen purchased the company's bioprocessing portfolio. Prior to 908 Devices, Dr. Brown was a platform architect at Apple Inc. (NASDAQ:AAPL) lead
SC 13G/A - Apple Inc. (0000320193) (Subject)
SC 13G/A - Apple Inc. (0000320193) (Subject)
SC 13G/A - Apple Inc. (0000320193) (Subject)